UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $162,000 | +161.3% | 405,500 | +271.2% | 0.00% | – |
| Q2 2022 | $62,000 | -78.0% | 109,251 | -56.5% | 0.00% | – |
| Q1 2022 | $282,000 | -77.4% | 251,295 | -70.7% | 0.00% | – |
| Q4 2021 | $1,250,000 | +67.1% | 856,442 | +243.5% | 0.00% | – |
| Q3 2021 | $748,000 | +32.9% | 249,342 | +105.4% | 0.00% | – |
| Q2 2021 | $563,000 | -49.2% | 121,411 | -34.3% | 0.00% | – |
| Q1 2021 | $1,109,000 | -20.8% | 184,750 | -30.8% | 0.00% | – |
| Q4 2020 | $1,400,000 | +255.3% | 266,908 | +134.4% | 0.00% | – |
| Q3 2020 | $394,000 | +13.2% | 113,883 | +184.1% | 0.00% | – |
| Q2 2020 | $348,000 | +86.1% | 40,082 | +24.2% | 0.00% | – |
| Q1 2020 | $187,000 | +122.6% | 32,264 | +134.5% | 0.00% | – |
| Q3 2019 | $84,000 | -74.7% | 13,757 | -60.6% | 0.00% | – |
| Q2 2019 | $332,000 | +242.3% | 34,908 | +193.3% | 0.00% | – |
| Q1 2019 | $97,000 | -45.2% | 11,900 | +9.0% | 0.00% | – |
| Q4 2018 | $177,000 | – | 10,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |